Search Within

Marc Ladanyi

  1. "College of American Pathologists"
Formats
  1. Journal Article (4)
  2. Review (1)
Groups
  1. Department of Pathology and Laboratory Medicine (5)
  2. GSK Faculty (5)
  3. Human Oncology and Pathogenesis Program (5)
  4. Tow Center for Developmental Oncology (TCDO) (5)
  5. Body Imaging Service (1)
  6. Center for Hematologic Malignancies (1)

More Groups

People
  1. Maria Arcila (3)
  2. Jaclyn Hechtman (1)
  3. Jinjuan Yao (1)
  4. Jonathan Killian (1)
  5. Mark Kris (1)
  6. Maureen Zakowski (1)

More People

Years
  1. 2021 (1)
  2. 2018 (1)
  3. 2016 (1)
  4. 2013 (1)
  5. 2009 (1)
Publications
  1. Archives of Pathology & Laboratory Medicine (5)
Publishers
  1. College of American Pathologists (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pan-cancer biomarkers: Changing the landscape of molecular testing
    Review

    Yao, J.; Arcila, M. E.; Ladanyi, M.; Hechtman, J. F.
    Archives of Pathology & Laboratory Medicine (2021)

    Fulltext@MSK | Save
  • Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase Inhibitors: Guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
    Journal Article

    Lindeman, N. I.; Cagle, P. T.; Aisner, D. L.; Arcila, M. E.; Beasley, M. B.; Bernicker, E. H.; Colasacco, C.; Dacic, S.; Hirsch, F. R.; Kerr, K.; more...
    Archives of Pathology & Laboratory Medicine (2018)

    Fulltext@MSK | Save
  • Optimizing workflows and processing of cytologic samples for comprehensive analysis by next-generation sequencing: Memorial Sloan Kettering Cancer Center experience
    Journal Article

    Tian, S. K.; Killian, J. K.; Rekhtman, N.; Benayed, R.; Middha, S.; Ladanyi, M.; Lin, O.; Arcila, M. E.
    Archives of Pathology & Laboratory Medicine (2016)

    Fulltext@MSK | Save
  • Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
    Journal Article

    Lindeman, N. I.; Cagle, P. T.; Beasley, M. B.; Chitale, D. A.; Dacic, S.; Giaccone, G.; Jenkins, R. B.; Kwiatkowski, D. J.; Saldivar, J. S.; Squire, J.; more...
    Archives of Pathology & Laboratory Medicine (2013)

    Fulltext@MSK | Save
  • Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib
    Journal Article

    Zakowski, M. F.; Hussain, S.; Pao, W.; Ladanyi, M.; Ginsberg, M. S.; Heelan, R.; Miller, V. A.; Rusch, V. W.; Kris, M. G.
    Archives of Pathology & Laboratory Medicine (2009)

    Fulltext@MSK | Save